Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesko

Showing results (811-820 of 1,126) with videos related to

Pageof 113
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2022
Time Between Viral Loads for People With HIV During the COVID-19 PandemicWalid G El-Nahal, Nicola M Shen, Jeanne C Keruly, et al.
Annals of Epidemiology|September 24, 2017
Mortality under plausible interventions on antiretroviral treatment and depression in HIV-infected women: an application of the parametric g-formulaCatherine R Lesko, Jonathan V Todd, Stephen R Cole, et al.
The International Journal on Drug Policy|September 23, 2023
Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomesOluwaseun Falade-Nwulia, Tracy Agee, Sharon M Kelly, et al.
AIDS (London, England)|February 25, 2026
Targeted cuts to Ryan White programs could raise HIV incidence by 8-17% in 30 US states and the District of ColumbiaAndrew Zalesak, Melissa Schnure, Ryan Forster, et al.
Molecular Pharmaceutics|July 20, 2005
The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugsLawrence X Yu, Arthur B Straughn, Patrick J Faustino, et al.
Biopharmaceutics & Drug Disposition|January 25, 2012
Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practiceJoseph A Grillo, Ping Zhao, Julie Bullock, et al.
International Journal of Neonatal Screening|September 22, 2025
Next-Generation Sequencing in the Diagnostic Workup of Neonatal Dried Blood Spot Screening in Sweden 2015-2023Lene Sörensen, Jorge Asin-Cayuela, Michela Barbaro, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 7, 2023
Association of preoperative opioid use and postoperative complications following breast reconstructionMichael A Cheah, Samuel Sarmiento, Robert P Lesko, et al.
Journal of Clinical Pharmacology|May 16, 2019
Evaluating the Clinical Impact of Formulation Variability: A Metoprolol Extended-Release Case StudySarah Kim, Vishnu D Sharma, Karthik Lingineni, et al.
Thrombosis and Haemostasis|November 26, 2011
The Creating an Optimal Warfarin Nomogram (CROWN) StudyTodd S Perlstein, Samuel Z Goldhaber, Kerrie Nelson, et al.
Pageof 113

Showing results (811-820 of 1,126) with videos related to

Sort By:
Pageof 113
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2022
Time Between Viral Loads for People With HIV During the COVID-19 PandemicWalid G El-Nahal, Nicola M Shen, Jeanne C Keruly, et al.
Annals of Epidemiology|September 24, 2017
Mortality under plausible interventions on antiretroviral treatment and depression in HIV-infected women: an application of the parametric g-formulaCatherine R Lesko, Jonathan V Todd, Stephen R Cole, et al.
The International Journal on Drug Policy|September 23, 2023
Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomesOluwaseun Falade-Nwulia, Tracy Agee, Sharon M Kelly, et al.
AIDS (London, England)|February 25, 2026
Targeted cuts to Ryan White programs could raise HIV incidence by 8-17% in 30 US states and the District of ColumbiaAndrew Zalesak, Melissa Schnure, Ryan Forster, et al.
Molecular Pharmaceutics|July 20, 2005
The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugsLawrence X Yu, Arthur B Straughn, Patrick J Faustino, et al.
Biopharmaceutics & Drug Disposition|January 25, 2012
Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practiceJoseph A Grillo, Ping Zhao, Julie Bullock, et al.
International Journal of Neonatal Screening|September 22, 2025
Next-Generation Sequencing in the Diagnostic Workup of Neonatal Dried Blood Spot Screening in Sweden 2015-2023Lene Sörensen, Jorge Asin-Cayuela, Michela Barbaro, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 7, 2023
Association of preoperative opioid use and postoperative complications following breast reconstructionMichael A Cheah, Samuel Sarmiento, Robert P Lesko, et al.
Journal of Clinical Pharmacology|May 16, 2019
Evaluating the Clinical Impact of Formulation Variability: A Metoprolol Extended-Release Case StudySarah Kim, Vishnu D Sharma, Karthik Lingineni, et al.
Thrombosis and Haemostasis|November 26, 2011
The Creating an Optimal Warfarin Nomogram (CROWN) StudyTodd S Perlstein, Samuel Z Goldhaber, Kerrie Nelson, et al.
Pageof 113